Fingerpaint acquired Parsons Medical Communications (PMC), which offers scientific communications to the eye care industry, the agency said Wednesday. Terms were not disclosed.

The Boston-based firm will operate as a specialty unit within Fingerpaint Group. Its founder, Erin Parsons, will continue to lead her three-person team as managing director, reporting to Scott Goudy, president of Fingerpaint’s MedThink Group. 

A full-service company, PMC provides scientific strategy and medical communications, as well as advocacy development and peer-to-peer educational programs, for the ophthalmic segment. 

The acquisition marks Fingerpaint’s sixth since December 2020, when it took on private equity partner Knox Lane, and its second in the past three months, following the addition of multicultural agency Emcay in July.

Fingerpaint’s 2021 revenue rose to $135 million from $85 million in 2020, according to the 2022 MM+M Agency 100.